Sunshine Biopharma: Alta reports 4.905% stake

Sunshine Biopharma Inc. (SBFM) is the issuer in Alta Partners LLC’s amended ownership report: Alta reported beneficial ownership of 200,000 common shares issuable upon exercise of outstanding warrants, equal to 4.905% of the class.

Rhea-AI Filing Summary

Sunshine Biopharma Inc. (SBFM) is the issuer in Alta Partners LLC’s amended ownership report: Alta reported beneficial ownership of 200,000 common shares issuable upon exercise of outstanding warrants, equal to 4.905% of the class. Alta reported sole voting and dispositive power over 200,000 shares and no shared voting or dispositive power. Steven Cohen signed as Managing Member.

Key Figures

Beneficial ownership: 200,000 shares Percent of class: 4.905% Sole voting power: 200,000 shares +3 more

6 metrics

Beneficial ownership 200,000 shares Common shares issuable upon exercise of outstanding warrants

Percent of class 4.905% Alta Partners LLC beneficial ownership

Sole voting power 200,000 shares Alta Partners LLC

Shared voting power 0 shares Alta Partners LLC

Sole dispositive power 200,000 shares Alta Partners LLC

Shared dispositive power 0 shares Alta Partners LLC

Key Terms

beneficially owned, outstanding warrants, sole dispositive power, shared voting power

4 terms

beneficially owned financial

"Amount beneficially owned: 200,000 shares of common stock"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

outstanding warrants financial

"shares of common stock issuable upon exercise of outstanding warrants"

sole dispositive power regulatory

"Sole power to dispose or to direct the disposition of"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

shared voting power regulatory

"Shared power to vote or to direct the vote"

Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many SBFM shares does Alta Partners LLC report beneficially owning?

Alta Partners LLC reported beneficial ownership of 200,000 Sunshine Biopharma Inc. common shares issuable upon exercise of outstanding warrants.

What percentage of SBFM does Alta Partners LLC report owning?

Alta Partners LLC reported beneficial ownership equal to 4.905% of the class.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/05/2026 - 04:07 PM Accepted by SEC EDGAR 10/05/2026 - 04:06 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

Sunshine Biopharma Inc.

(Name of Issuer)

Common Stock, par value $0.001 per share

(Title of Class of Securities)

867781809

(CUSIP Number)

08/13/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 867781809

1

Names of Reporting Persons

Alta Partners LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

NEW YORK

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 200,000.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 200,000.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

200,000.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.9 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Sunshine Biopharma Inc.
(b)	Address of issuer's principal executive offices: 333 LAS OLAS WAY, CU4 SUITE 433, FORT LAUDERDALE, FLORIDA, 33301.
Item 2.
(a)	Name of person filing: Alta Partners LLC
(b)	Address or principal business office or, if none, residence: 1205 Franklin Avenue Garden City, New York 11530
(c)	Citizenship: New York Limited Liability Company
(d)	Title of class of securities: Common Stock, par value $0.001 per share
(e)	CUSIP No.: 867781809
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 200,000 shares of common stock, representing shares of common stock issuable upon exercise of outstanding warrants.
(b)	Percent of class: 4.905%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 200,000 shares of common stock
	(ii) Shared power to vote or to direct the vote: 0 shares of common stock
	(iii) Sole power to dispose or to direct the disposition of: 200,000 shares of common stock
	(iv) Shared power to dispose or to direct the disposition of: 0 shares of common stock
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Alta Partners LLC

Signature:	/s/ Steven Cohen
Name/Title:	Steven Cohen, Managing Member
Date:	10/05/2026